NM_001378156.1:c.60C>A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001378156.1(C1QB):​c.60C>A​(p.Ile20Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00163 in 1,614,028 control chromosomes in the GnomAD database, including 47 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. I20I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0086 ( 23 hom., cov: 32)
Exomes 𝑓: 0.00091 ( 24 hom. )

Consequence

C1QB
NM_001378156.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -4.53

Publications

1 publications found
Variant links:
Genes affected
C1QB (HGNC:1242): (complement C1q B chain) This gene encodes the B-chain polypeptide of serum complement subcomponent C1q, which associates with C1r and C1s to yield the first component of the serum complement system. C1q is composed of 18 polypeptide chains which include 6 A-chains, 6 B-chains, and 6 C-chains. Each chain contains an N-terminal collagen-like region and a C-terminal C1q globular domain. C1q deficiency is associated with lupus erythematosus and glomerulonephritis. [provided by RefSeq, Dec 2016]
C1QB Gene-Disease associations (from GenCC):
  • C1Q deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 1-22659522-C-A is Benign according to our data. Variant chr1-22659522-C-A is described in ClinVar as [Benign]. Clinvar id is 775523.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.53 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00859 (1307/152200) while in subpopulation AFR AF = 0.0302 (1254/41498). AF 95% confidence interval is 0.0288. There are 23 homozygotes in GnomAd4. There are 626 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C1QBNM_001378156.1 linkc.60C>A p.Ile20Ile synonymous_variant Exon 2 of 3 ENST00000509305.6 NP_001365085.1
C1QBNM_000491.5 linkc.66C>A p.Ile22Ile synonymous_variant Exon 2 of 3 NP_000482.3 P02746A0A024RAB9
C1QBNM_001371184.3 linkc.60C>A p.Ile20Ile synonymous_variant Exon 3 of 4 NP_001358113.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C1QBENST00000509305.6 linkc.60C>A p.Ile20Ile synonymous_variant Exon 2 of 3 1 NM_001378156.1 ENSP00000423689.1 D6R934

Frequencies

GnomAD3 genomes
AF:
0.00857
AC:
1304
AN:
152082
Hom.:
24
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0302
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00527
GnomAD2 exomes
AF:
0.00227
AC:
571
AN:
251338
AF XY:
0.00163
show subpopulations
Gnomad AFR exome
AF:
0.0317
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.0000968
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000907
AC:
1326
AN:
1461828
Hom.:
24
Cov.:
32
AF XY:
0.000806
AC XY:
586
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.0319
AC:
1069
AN:
33478
American (AMR)
AF:
0.000984
AC:
44
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86248
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00243
AC:
14
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000468
AC:
52
AN:
1111984
Other (OTH)
AF:
0.00229
AC:
138
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
73
147
220
294
367
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00859
AC:
1307
AN:
152200
Hom.:
23
Cov.:
32
AF XY:
0.00841
AC XY:
626
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0302
AC:
1254
AN:
41498
American (AMR)
AF:
0.00216
AC:
33
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
67992
Other (OTH)
AF:
0.00521
AC:
11
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
63
126
190
253
316
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00146
Hom.:
1
Bravo
AF:
0.00982
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000273
EpiControl
AF:
0.000296

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

C1QB-related disorder Benign:1
Jul 11, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.11
DANN
Benign
0.51
PhyloP100
-4.5
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77379868; hg19: chr1-22986015; API